PT Itama Ranoraya Tbk Reports Earnings Results for the Half Year Ended June 30, 2023
September 27, 2023 at 03:08 am
Share
PT Itama Ranoraya Tbk reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was IDR 224,952.92 million compared to IDR 442,159.05 million a year ago. Net income was IDR 12,618.73 million compared to IDR 35,783.44 million a year ago.
Basic earnings per share from continuing operations was IDR 8 compared to IDR 23 a year ago. Diluted earnings per share from continuing operations was IDR 8 compared to IDR 23 a year ago.
PT Itama Ranoraya Tbk is an Indonesia-based healthcare company, which is engaged in offering healthcare solutions. The Company operates in the field of wholesale trading of laboratory equipment, pharmaceutical equipment, and medical devices for humans. The Company carries out its operations through four products, namely the non-electromedical sterile medical devices, in-vitro diagnostic, electromedical sterile medical devices, and other products. Its business segment focuses on in-vitro diagnostic (IVD), medical imaging, surgical instrument and disposable, critical care, blood banking and transfusion, cardiovascular, brain management, cancer, urology, and maternal and neonatal care. Its products include Oneject, Abbott, Terumo, Becton Dickinson (BD), HMD, Vestfrost, Balmed, iGene, AVIMAC, and HemoCue.